WHO recommendations on the use of diphtheria-containing vaccines for outbreak prevention and response, October 2026

Overview

Since the establishment of the Expanded Programme on Immunization more than 50 years ago, diphtheria toxoid-containing vaccines have been a cornerstone of global immunization efforts, contributing to a dramatic decline in diphtheria morbidity and mortality.

However, current diphtheria outbreaks, particularly in countries across the African and Eastern Mediterranean Regions reflect population-level immunity gaps associated with low coverage of the WHO recommended three-dose primary series and lack or insufficient uptake of the three recommended booster doses.

This document was developed based on guidance from the Strategic Advisory Group of Experts on Immunization (SAGE) provided at its October 2026 meeting. The full SAGE meeting report will be published in the Weekly Epidemiological Record on 18 December 2026. These recommendations should be considered as complementary to the existing WHO Position Paper on diphtheria vaccines, published in 2017.


 

WHO Team
Immunization, Vaccines and Biologicals (IVB)
Number of pages
7
Copyright
WHO